To address the global challenge of antibiotic overuse, alternative strategies including inorganic nanoparticles, photothermal therapy, and photodynamic therapy have been developed in recent years. However, their clinical translation has been hindered by complicated manufacturing processes and high production costs. This study successfully developed a pH-responsive chitosan-based hydrogel via an environmentally friendly Schiff base reaction, leveraging the dual inherent antibacterial and antioxidant properties of both chitosan (CS) and protocatechualdehyde (PA). The chitosan-protocatechualdehyde (CS-PA) hydrogel exhibited superior swelling capacity, excellent injectability, and potent antioxidant and antibacterial activities. Antibacterial experiments demonstrated that the CS-PA hydrogel significantly inhibited the growth of Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), with the CS-PA200 hydrogel achieving complete inhibition of both bacteria within 24 h. These results establish the CS-PA hydrogel as a clinically promising, antibiotic-free platform for combating drug-resistant infections while promoting wound regeneration.
扫码关注我们
求助内容:
应助结果提醒方式:
